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Cognitive ability and physical 
health: a Mendelian randomization 
study
Saskia P. Hagenaars  1,2,3, Catharine R. Gale1,2,4, Ian J. Deary1,2 & Sarah E. Harris1,5
Causes of the association between cognitive ability and health remain unknown, but may reflect a 
shared genetic aetiology. This study examines the causal genetic associations between cognitive 
ability and physical health. We carried out two-sample Mendelian randomization analyses using the 
inverse-variance weighted method to test for causality between later life cognitive ability, educational 
attainment (as a proxy for cognitive ability in youth), BMI, height, systolic blood pressure, coronary 
artery disease, and type 2 diabetes using data from six independent GWAS consortia and the UK 
Biobank sample (N = 112 151). BMI, systolic blood pressure, coronary artery disease and type 2 diabetes 
showed negative associations with cognitive ability; height was positively associated with cognitive 
ability. The analyses provided no evidence for casual associations from health to cognitive ability. 
In the other direction, higher educational attainment predicted lower BMI, systolic blood pressure, 
coronary artery disease, type 2 diabetes, and taller stature. The analyses indicated no causal association 
from educational attainment to physical health. The lack of evidence for causal associations between 
cognitive ability, educational attainment, and physical health could be explained by weak instrumental 
variables, poorly measured outcomes, or the small number of disease cases.
Lower cognitive ability, lower educational attainment and greater cognitive decline are all associated with poorer 
health outcomes1–3. Some of these associations possibly arise because of the effect of lower cognitive ability in 
childhood on later life health, others because illnesses may lower cognitive ability in later life. The causes of these 
associations are unclear, but some may reflect, in part, a shared genetic aetiology. Recent papers have reported 
genetic associations between cognitive ability and educational attainment, and a number of physical and mental 
health traits and diseases4–6. These4, 6, and other papers7–9, have shown successful use of educational attainment 
as a proxy for cognitive ability, showing phenotypic correlations between educational attainment and general 
cognitive ability around 0.509 and a genetic correlation of 0.724.
Some of the reciprocal phenotypic associations between cognitive and physical health variables, and their 
genetic correlations, are as follows. Short stature has been consistently linked with lower cognitive ability10, 11. 
Molecular genetic studies have indicated positive genetic correlations between height and cognitive ability4, 12, as 
well as between height and educational attainment4, 5. Higher polygenic scores for height have been associated 
with better cognitive ability in adulthood4. A causal association was reported between taller stature and educa-
tional attainment (not including individuals with a degree) in UK Biobank using a Mendelian randomization 
analysis13.
Multiple studies have shown associations between cognitive ability and cardiovascular risk factors. For exam-
ple, lower childhood cognitive ability is associated with subsequent high blood pressure14 and obesity15. However, 
higher BMI in mid-life16 and both hypertension and hypotension17 are associated with lower cognitive ability 
and greater cognitive decline in later life. A negative genetic correlation has been identified between BMI, but 
not blood pressure, and educational attainment and cognitive ability in mid to late life4, 5, and a polygenic score 
for higher BMI is associated with lower cognitive ability in mid to late life and lower educational attainment4; 
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however, a polygenic score for higher systolic blood pressure is associated with lower educational attainment, but 
higher cognitive ability in mid to late life4.
Similarly, associations have been identified between cognitive ability and cardio metabolic diseases. 
Childhood cognitive ability has been associated with developing diabetes18 and coronary artery disease19 later in 
life. Diabetes20 and coronary artery disease21, 22 in midlife have been associated with greater cognitive decline later 
in life. A polygenic risk score for type 2 diabetes is associated with lower educational attainment, but not with 
cognitive ability in mid to late life4, although one has been associated with reduced cognitive decline23. To date, no 
genetic correlation between diabetes and cognitive ability has been identified4, 5. A polygenic risk score for cor-
onary artery disease is associated with lower educational attainment and lower mid to late life cognitive ability4, 
and a negative genetic correlation was identified between coronary artery disease and educational attainment4, 5, 
but not cognitive ability in mid to late life4.
The question arises as to whether the genetic cognitive-health associations caused by: (1) genes influencing 
health traits/diseases, and then those health traits/diseases subsequently influencing cognitive ability; (2) genes 
influencing cognitive ability, and then cognitive ability subsequently influencing health traits/diseases; (3) genes 
influencing general bodily system integrity24 that influences both cognitive ability and health traits/diseases?
To try to make some progress in understanding causality of the correlation between cognitive ability and a 
number of physical and mental health traits, in the present report we used a bidirectional, two-sample Mendelian 
randomization (MR) approach25. MR uses genetic variants as proxies for environmental exposures and is subject 
to the following assumptions: (1) the genetic variants are associated with the exposure; (2) the genetic variants are 
only associated with the outcome of interest via their effect on the exposure [i.e., there is no biological pleiotropy 
(the phenomenon whereby one SNP independently influences multiple traits), also called the exclusion restric-
tion]; and 3) the genetic variants are independent of confounders. Figure 1 shows the Mendelian randomization 
study model; the instrumental variable, here based on genome-wide significant SNPs from independent studies 
for the exposure, is used to estimate if the exposure (e.g. BMI) causally influences the outcome (e.g. cognitive 
ability). Individual single nucleotide polymorphisms (SNPs) are often found to be weak instruments for investi-
gating causality because they often have small effect sizes. Using multiple SNPs can increase the strength of the 
instrument. However, this increases the chance of violating the MR assumptions, specifically violation of the 
assumption that the genetic variants affect the outcome only via the exposure. We used multiple genetic variants 
for a number of health-related traits and diseases, previously identified in genome-wide association studies, as 
instrumental variables to see if they predicted cognitive ability (verbal-numerical reasoning) in mid to later life in 
the UK Biobank. We then used genome-wide significant educational attainment SNPs as an instrumental variable 
to test whether genetic differences associated with educational attainment (a proxy measure of cognitive ability in 
early life6, 8) predict later life health outcomes in the UK Biobank.
Methods
Sample. This study uses baseline data from the UK Biobank Study, a large resource for identifying determi-
nants of human diseases in middle aged and older individuals26. Around 500 000 community-dwelling partic-
ipants aged between 37 and 73 years were recruited and underwent assessments between 2006 and 2010 in the 
United Kingdom. This included cognitive and physical assessments, providing blood, urine and saliva samples for 
Figure 1. Model for Mendelian randomization study. The instrumental variable, based on genome-wide 
significant SNPs from independent studies for the exposure, is used to estimate if the exposure (e.g. BMI) 
causally influences the outcome (e.g. cognitive ability). The instrumental variable should be unrelated to 
potential confounders of the exposure-outcome association and should only affect the outcome via the 
exposure.
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future analysis, and giving detailed information about their backgrounds and lifestyles, and agreeing to have their 
health followed longitudinally. For the present study, genome-wide genotyping data were available on 112 151 
individuals (58 914 females) aged 40–70 years (mean age = 56.9 years, SD = 7.9) after the quality control process 
which is described in more detail elsewhere4. The UK Biobank study was approved by the National Health Service 
(NHS) Research Ethics Service (approval letter dated 17th June 2011, reference: 11/NW/0382). The analyses in 
the present report were completed under UK Biobank application 10279. All experiments were performed in 
accordance with guidelines and regulations from these committees. Written informed consent was obtained from 
each subject.
Measures. Body mass index. Body mass index (BMI) was calculated as weight(kg)/height(m)2, and meas-
ured using an impedance measure, i.e. a Tanita BC418MA body composition analyser, to estimate body composi-
tion. We used the average of the two methods when both measures were available (r = 0.99); if only one measure 
was available, that measure was used (N = 1629). 291 individuals did not have information on BMI. One outlier 
was excluded based on visual inspection of the BMI distribution (BMI > 50). 111 712 individuals had valid BMI 
and genetic data.
Height. Standing and sitting height (cm) were measured using a Seca 202 device. We used standing height and 
excluded one individual based on the visual inspection of the height distribution with a standing height <125 cm 
and a sitting/standing height ratio <0.75. 111 959 had valid height and genetic data.
Systolic blood pressure. Systolic blood pressure was measured twice, a few moments apart, using the Omron 
Digital blood pressure monitor. A manual sphygmomanometer was used if the digital blood pressure monitor 
could not be employed (N = 6652). Systolic blood pressure was calculated as the average of measures at the two 
time points (for either automated or manual readings). Individuals with a history of coronary artery disease were 
excluded from the analysis (N = 2513). Following the recommendation by Tobin, et al.27, 15 mmHg was added to 
the average systolic blood pressure of individuals taking antihypertensive medication (N = 10 988). Individuals 
with a systolic blood pressure (after correcting for medication) more than 4 SD from the mean were excluded 
from future analyses (N = 75). After all exclusions, 106 759 individuals remained with valid blood pressure and 
genetic data.
Coronary artery disease. UK Biobank participants completed a touch screen questionnaire on past and cur-
rent health, which included the question “Has a doctor ever told you that you have had any of the following 
conditions? heart attack/angina/stroke/high blood pressure/none of the above/prefer not to answer”. This was 
followed by a verbal interview with a trained nurse who was made aware if the participant had a history of cer-
tain illnesses and confirmed these diagnoses with the participant. For the present study, coronary artery disease 
was defined as a diagnosis of myocardial infarct or angina, reported during both the touchscreen and the verbal 
interview in individuals with genetic data (N = 5288). The control group (N = 104 784) consisted of participants 
who reported none of the following diseases (based on the non-cancer illness code provided by UK Biobank): 
myocardial infarction, angina, heart failure, cerebrovascular disease, stroke, transient ischaemic attack, subdural 
haemorrhage, cerebral aneurysm, peripheral vascular disease, leg claudication/intermittent claudication, arterial 
embolism.
Type 2 diabetes. Type 2 diabetes case-control status was created using the same method as described by Wood, et al.28, 
for all individuals with genetic data based on the interim release of UK Biobank. Cases included participants who 
reported type 2 diabetes or generic diabetes during the nurse interview, started insulin treatment at least one year 
after diagnosis, were older than 35 years at the time of diagnosis, and did not receive a diagnosis one year prior to 
baseline testing (N = 3764). The control group consisted of participants who did not fulfil these criteria, and did 
not report a diagnosis of type 1 diabetes, diabetes insipidus and gestational diabetes (N = 108 015).
Years of education. As part of the sociodemographic questionnaire in the study, participants were asked, “Which 
of the following qualifications do you have? (You can select more than one)”. Possible answers were: “College or 
University Degree/A levels or AS levels or equivalent/O levels or GCSE or equivalent/CSEs or equivalent/NVQ 
or HND or HNC or equivalent/Other professional qualifications e.g. nursing, teaching/None of the above/Prefer 
not to answer”. For the present study, a new continuous variable was created measuring ‘years of education com-
pleted’. This was based on the ISCED coding, using the 1997 International Standard Classification of Education 
(ISCED) of the United Nations Educational, Scientific and Cultural Organization29. See the Table 1 for further 
details. Individuals who reported that they had a NVQ or HND or HNC degree, individuals who reported other 
qualifications, and individuals who preferred not to answer were excluded from analyses. The reason for these 
exclusions was as follows: the first two categories would correspond to 15 and 19 years of education according 
to the ISCED coding; regarding their mean scores on cognitive ability tests, this might not be the right place for 
these two degree levels in the ordered hierarchy of educational attainments (Supplementary Figure 1). For the 
current study, years of education was used a proxy phenotype for cognitive ability4, 6, 8. A total of 97,550 individu-
als had valid data for the years of education variable.
Cognitive ability. Cognitive ability was measured using a 13-item touchscreen computerized verbal-numerical 
reasoning test. The test included six verbal and seven numerical questions, all with multiple-choice answers, with 
a two-minute time limit. An example verbal item is: ‘If some flinks are plinks and some plinks are stinks then 
some flinks are definitely stinks?’ (possible answers: ‘True/False/Neither-true-nor-false/do not know/prefer not to 
answer’). An example numerical item is: ‘If sixty is more than half of seventy-five, multiply twenty-three by three. 
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If not subtract 15 from eighty-five. Is the answer?’ (possible answers: ‘68/69/70/71/72/do not know/prefer not to 
answer’). The cognitive ability score was the total score out of 13 (further detail can be found in Hagenaars, et al.4). 
This test was introduced at a later stage during baseline assessment and only a subset of individuals therefore 
completed this test. A total of 36 035 had valid cognitive ability and genetic data.
Covariates. All analyses were adjusted for the following covariates: age when attending assessment centre, 
sex, genetic batch and array, and the first ten genetic principal components for population stratification.
Instrumental variables. SNPs associated with each of the five health outcomes and educational attain-
ment were retrieved from the largest available GWAS in European samples for the variables of interest (BMI30, 
height28, systolic blood pressure31, coronary artery disease32, type 2 diabetes33, and educational attainment34). 
For educational attainment, we downloaded the summary statistics based on the discovery GWAS only, which 
did not include the UK Biobank sample. Corresponding SNPs used in the instrumental variables were then 
extracted from the imputed UK Biobank’s interim release of genotypes, which amounted to 112 151 individuals 
of self-reported White British ancestry after quality control. Details on the quality control process have been 
published previously4. SNPs out of Hardy-Weinberg equilibrium (HWE, p < 1 × 10−6), with an imputation qual-
ity below 0.9, or individual genotypes with a genotype probability below 0.9 and strand ambiguous SNPs were 
excluded from the instrumental variables. The individual variants were recoded as 0, 1 or 2 according to the num-
ber of trait increasing alleles. Table 2 includes information on the number of SNPs included, and the reference 
paper. Supplementary Table 3a–f provides details of the included SNPs.
Statistical analysis. Phenotypic associations. We performed linear regression analysis using BMI, height, 
systolic blood pressure, coronary artery disease, and type 2 diabetes to predict cognitive ability. We regressed 
BMI, height, and systolic blood pressure against educational attainment in a linear regression model; coronary 
artery disease and type 2 diabetes were regressed against educational attainment in logistic regression models.
Mendelian randomization analysis. The Mendelian randomization analysis was performed using inverse var-
iance weighted regression analysis based on SNP level data, with each instrumental variable (IV) consisting of 
multiple SNPs25. The inverse variance weighted method is based on a regression of two vectors with the inter-
cept constrained to zero, i.e. the genetic variant with the exposure association, and the genetic variant with the 
outcome association (Fig. 1). By constraining the intercept to zero, this method assumes that all variants are 
valid instrumental variables based on the Mendelian randomization assumptions. We performed an association 
analysis between each SNP in the instrumental variable for the exposure and the exposure itself (IV - expo-
sure), as well as between the instrumental variable for the exposure and the outcome (IV - outcome). We then 
used the vector of the instrumental variable-outcome association analyses against the vector of the instrumental 
variable-exposure analyses. This association (vector IV - outcome ~ vector IV - exposure) was weighted by the 
standard error of the original IV-outcome association, to correct for minor allele frequency, as described by 
Bowden, et al.25. Power calculations for the MR analyses can be found in Supplementary Table 1. No sensitivity 
analyses were performed due to the lack of causal associations.
Results
Health outcomes predicting cognitive ability. BMI, height, systolic blood pressure, and coronary 
artery disease predicted performance on the verbal-numerical reasoning test of cognitive ability (Table 3). A 1 SD 
higher BMI was associated with a 0.05 SD lower score for cognitive ability (β = −0.05, 95% CI = −0.06, −0.04). A 
1 SD greater height was associated with a 0.18 SD higher score for cognitive ability (β = 0.18, 95% CI = 0.17, 0.20). 
A 1 SD higher systolic blood pressure was associated with a 0.05 SD lower score for cognitive ability (β = −0.05, 
95% CI = −0.06, −0.04). Individuals with coronary artery disease had, on average, a 0.27 SD lower score for 
cognitive ability (β = −0.27, 95% CI = −0.32, −0.21). Individuals with type 2 diabetes had, on average, a 0.06 SD 
lower score for cognitive ability (β = −0.06, 95% CI = −0.12, 0.01). The Mendelian randomization inverse vari-
ance weighted analyses, with the five health outcomes as the exposures, and cognitive ability as the outcome, did 
not provide any causal evidence for any of these associations.





Years of education 
(based on ISCED code) N
College or university degree 1 5 20 (19 + 1) 33852
A levels/AS levels or equivalent 2 3 13 12560
O levels/GCSEs or equivalent 3 2 10 24802
CSEs or equivalent 4 2 10 6064
NVQ or HND or HNC or equivalent 5 NA NA 7788
Other professional qualification eg: 
nursing, teaching 6 NA NA 5776
None of the above −7 1 7 20272
Prefer not to answer −3 NA NA 953
Table 1. Coding for years of education in UK Biobank based on the ISCED coding29. ISCED, 1997 International 
Standard Classification of Education of the United Nations Educational, Scientific and Cultural Organization.
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Education predicting health outcomes. Educational attainment, as measured by years of education, 
predicted BMI, height, systolic blood pressure, type 2 diabetes and coronary artery disease (Table 4). The differ-
ence between 7 and 20 years of education was associated with a 0.37 SD lower BMI (β = −0.37, 95% CI = −0.39, 
−0.35), 0.31 SD taller stature (β = 0.31, 95% CI = 0.30, 0.32), 0.20 lower SBP (β = −0.20, 95% CI = −0.22, −0.19), 
0.58 lower odds of type 2 diabetes (OR = 0.58, 95% CI = 0.52, 0.64), and 0.40 lower odds of coronary artery 
disease (OR = 0.40, 95% CI = 0.37, 0.43). The differences between the other groups (7 versus 10 and 13 years of 
education) can be found in Supplementary Table 2. In every case, the Mendelian randomization inverse variance 
weighted method did not show a causal effect of educational attainment on the health outcomes. The full results 
can be found in Table 4.
Discussion
This study was designed to investigate causes of the well replicated finding that lower cognitive ability is asso-
ciated with poorer health outcomes1–3. It used a bidirectional two-sample MR approach to investigate this. We 
found no evidence for causal association between several health outcomes and cognitive ability, in middle and 
older age, or between educational attainment and physical health.
Tyrrell, et al.13 showed a causal association between taller stature and time spent in full time education in 
UK Biobank. They did not find a causal association between taller stature and degree level. The measure of time 
spent in full time education in UK Biobank excluded individuals who reported having a college degree, which 
could explain the discrepancy in results. The current study did include individuals who reported having a college 
degree, however used a categorical measure of four categories, whereas Tyrrell, et al.13 used a continuous measure 
of time spent in full time education. In a non-peer-reviewed (at the time of writing) study, Tillmann, et al.35 did 
report a causal association from educational attainment to coronary artery disease and BMI using a two-sample 
MR approach based on two independent consortia35. They used data from two independent GWAS consortia, 
including 349,306 individuals for educational attainment, 194,427 (63,746 cases) individuals for coronary artery 
disease, and 339,224 individuals for BMI. The current study used the same data for educational attainment on a 
subset of individuals (N = 293,723), and 111,712 individuals with BMI data; however, coronary artery disease was 
based on self-report diagnosis in UK Biobank, which included 110,072 (5288 cases) individuals. The summary 
level data for coronary artery disease in the Tillmann, et al.35 report included both European and East-Asian 
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Table 2. Information about instrumental variables.
Cognitive ability
Phenotypic: health outcomes – cognitive 
ability
MR-IVW: health SNPs – cognitive 
ability
SNPs (nr) Beta 95% CI p Beta 95% CI p
BMI (70) −0.049 −0.059, −0.039 1.51 × 10−20 −0.035 −0.147, 0.077 0.5439
Height (331) 0.1816 0.166, 0.197 5.53 × 10−124 0.026 −0.009, 0.061 0.1329
Systolic blood pressure (20) −0.0492 −0.061, −0.037 2.24 × 10−17 −0.002 −0.010, 0.006 0.6355
Coronary artery disease (19) −0.2651 −0.316, −0.214 4.62 × 10−25 −0.018 −0.045, 0.009 0.2343
Type 2 diabetes (9) −0.0634 −0.120, −0.007 0.0292 0.010 −0.019, 0.039 0.5316
Table 3. Phenotypic and genetic associations, using Mendelian randomization analysis, between five health 
instrumental variables and cognitive ability, using the verbal-numerical reasoning test. Associations with a 
p-value < 0.05 are in bold. OR, odds ratio; MR-IVW, Mendelian randomization - inverse variance weighted 
method.
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overlapping cohorts between educational attainment and coronary artery disease data; however, it is unclear if 
overlapping cohorts were excluded for BMI.
Another explanation for the lack of causal associations in the present study could be the high polygenic aeti-
ology of the traits analysed in this study. Instrumental variables for cardiovascular disease, type 2 diabetes, blood 
pressure, and educational attainment explain a small amount of the variance in the exposure. A better instrumen-
tal variable would be expected to explain a substantial amount of the variance of the exposure. As shown by the 
power calculations (Supplementary Table 1), all instrumental variables (except BMI and systolic blood pressure) 
had sufficient power to detect the same magnitude of association as the observational estimates. The low power 
for BMI and systolic blood pressure potentially explains the lack of association with cognitive ability. A previous 
study by the current authors indicated a degree of genetic overlap between cognitive ability and health across 
the genome4. The idea of genetic overlap between health and cognitive ability is consistent with the theoretical 
construct of bodily system integrity24, whereby a latent trait is manifest as individual differences in how effectively 
people meet cognitive and health challenges from the environment, and which has some genetic aetiology.
Strengths of this study include the large sample size of UK Biobank, the participants of which all took the 
same cognitive tests, completed the same questionnaires and answered the same interview questions, in contrast 
to most genetic studies, where assessments across different cohorts often vary. A further strength is the fact that 
all of the UK Biobank genetic data were processed in a consistent matter, on the same platform and at the same 
location. The genetic variants on which the instrumental variables originated used the largest available GWAS at 
moment of testing.
Limitations of this study include the fact that cognitive ability was only measured on a subset of the UK 
Biobank participants and that it was a bespoke test. A second major limitation was that there is no published large 
genome-wide association study of cognitive ability in early life from which we could obtain genetic variants to 
use as an instrumental variable. Therefore, we used genome-wide significant SNPs associated with educational 
attainment as our early life cognitive ability instrument. A further limitation is the case-control ascertainment in 
UK Biobank, as the current study based case-control status on self-report measures. This may have led to misclas-
sification of disease status, causing a likely bias towards the null hypothesis36.
Overall, this study found phenotypic cognitive-physical health associations, but did not find evidence for 
causal associations between cognitive ability and physical health. This may be due to weak instrumental varia-
bles, poorly measured outcomes, or the small numbers of disease cases. Future work should therefore focus on 
stronger instrumental variables, as well as better measurement of the outcome variables.
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